U.S. markets closed

BioSyent Inc. (BIOYF)

Other OTC - Other OTC Delayed Price. Currency in USD
6.270.00 (0.00%)
At close: 02:46PM EST
  • Dividend

    BIOYF announced a cash dividend of 0.045 with an ex-date of Feb. 28, 2024

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close6.27
Bid0.00 x 0
Ask0.00 x 0
Day's Range6.27 - 6.27
52 Week Range5.20 - 6.97
Avg. Volume1,718
Market Cap73.852M
Beta (5Y Monthly)0.93
PE Ratio (TTM)16.50
EPS (TTM)0.38
Earnings DateMar 19, 2024 - Mar 25, 2024
Forward Dividend & Yield0.13 (2.12%)
Ex-Dividend DateFeb 28, 2024
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for BIOYF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Technical Assessment: Neutral in the Intermediate-TermWhile the Nasdaq continues to flirt with (finally) printing an all-time high (ATH), the last of which was in November 2021 at 16,057.44, the Nasdaq 100 (QQQ) has been in ATH territory since December 2023. And yes, the ETF has cycled into overbought (OB) territory on a daily and weekly basis and is close to cycling into OB territory on a monthly basis.
    Fair Value
    Economic Moat
    16 hours agoArgus Research
View more
  • Simply Wall St.

    Why You Might Be Interested In BioSyent Inc. (CVE:RX) For Its Upcoming Dividend

    Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see BioSyent Inc...

  • GlobeNewswire

    BioSyent Named to 2024 TSX Venture 50

    MISSISSAUGA, Ontario, Feb. 21, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that it has been named to the 2024 TSX Venture 50 list as one of the top performers on the TSX Venture Exchange. The TSX Venture 50 is an annual ranking of the top performing companies from the past year on the TSX Venture Exchange. The TSX Venture 50 recognizes the top 10 companies from each of five sectors: Clean Technology and Life Sciences, Diversified Ind

  • GlobeNewswire

    BioSyent Declares First Quarter 2024 Dividend

    MISSISSAUGA, Ontario, Feb. 06, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.045 per common share, payable in Canadian Dollars on March 15, 2024, to shareholders of record at the close of business on February 29, 2024. This first quarter 2024 dividend of $0.045 per common share represents a 12.5% increase from the fourth quarter 2023 dividend of $0.040 per common share